Anna Choo Clinical Oncology Society of Australia Annual Scientific Meeting 2018

Abstracts this author is presenting:

• To evaluate the impact of a pharmacy driven protocol that converts standard rituximab infusions to subcutaneous for eligible patients. — Poster Session 1